AdvisorShares Psychedelics ETF (NYSEARCA:PSIL) Stock Short Interest Climbs 112.5%

AdvisorShares Psychedelics ETF (NYSEARCA:PSIL) was the recipient of a significant growth in short interest in October. As of October 15th, there was short interest totaling 79,632 shares, a growth of 112.5% from the September 30th total of 37,469 shares. Currently, 3.7% of the shares of the stock are short sold. Based on an average trading volume of 22,486 shares, the days-to-cover ratio is presently 3.5 days.

AdvisorShares Psychedelics ETF Price Performance

NYSEARCA:PSIL traded down $0.60 on Friday, reaching $21.00. The stock had a trading volume of 11,971 shares, compared to its average volume of 32,718. AdvisorShares Psychedelics ETF has a 12-month low of $15.63 and a 12-month high of $27.02. The firm’s fifty day moving average is $23.09 and its two-hundred day moving average is $20.71.

Hedge Funds Weigh In On AdvisorShares Psychedelics ETF

A hedge fund recently bought a new stake in AdvisorShares Psychedelics ETF stock. Vigilare Wealth Management acquired a new stake in shares of AdvisorShares Psychedelics ETF (NYSEARCA:PSIL) in the second quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor acquired 8,800 shares of the company’s stock, valued at approximately $212,000. Vigilare Wealth Management owned about 0.47% of AdvisorShares Psychedelics ETF as of its most recent filing with the Securities and Exchange Commission.

AdvisorShares Psychedelics ETF Company Profile

The AdvisorShares Psychedelics ETF (PSIL) is an exchange-traded fund that mostly invests in health care equity. The fund is actively managed to provide exposure to the emerging global psychedelics industry. PSIL was launched on Sep 15, 2021 and is managed by AdvisorShares.